Table 1.
Mechanism of actions of inhaled corticosteroids in asthma
Genomic | Non-genomic | |
---|---|---|
Action mediated through | Cytoplasmic glucocorticoid receptor-α [9]. | Membrane-bound or cytoplasmic glucocorticoid receptor or direct interaction with airway vasculature [11]. |
Onset of action | Hours to days [11]. | Seconds to minutes [11]. |
Effects | - Selective switch off in multiple activated inflammatory genes (transrepression) by reversal of histone acetylation [9, 15, 16]. - Increasing mRNA degradation and hence blocking production of pro-inflammatory cytokines [11]. - Increasing the synthesis of anti-inflammatory proteins [9]. |
- Suppressing the increased microvascular permeability and plasma leakage into the airway lumen [29–32]. - Acutely suppressing airway hyperperfusion in a dose-dependent manner [27]. - Inhibiting the remodeling process (only long-term therapy in a dose-dependent manner) [33, 34]. |